Let real-world evidence work for you.
Leverage clinical registry data to support device innovation and make more informed business decisions.
Reliance on registry data yields a high return on investment.
A recent article in the BMJ, written by representatives from industry, the FDA, and Fivos (formerly Medstreaming), revealed multiple benefits to using registry data.
Time to enroll patients in post-approval studies reduced from estimated 38 months to 21 months
Total costs saved in six industry studies
Time to acquire additional data for label expansion reduced from estimated 17 months to 5 months
Execute rapid, flexible, efficient, and cost-effective projects with Fivos.
Real-world evidence data services—based on registry data—provide our industry clients with governed, curated, and analyzed data sets tailored to their needs. Reports are accessible through a secure web portal, granting you access to customized project-specific data, providing the insight you need to move your projects forward.
Enable actionable intelligence with our powerful platform and expert team.
Analyze your product data efficiently and gain the tools necessary to enable actionable intelligence. As you steer your technology through each regulatory stage, our industry data services experts help you design a process that is expedient, cost-effective, and clinically successful.
We deliver an understanding of the product development process, and access to both professional society and custom databases that give you the flexibility to design new studies or undertake robust data mining and tailoring of existing data.